Pulmonary vascular disease & thromboembolism

Left Heart Abnormalities in Patients With Lung Disease, OSA, and Chronic Thromboemboli at Risk for or With Known Pulmonary Hypertension

Circ Heart FailPublished PVDOMICS study

Authors' conclusion

Quantifying pretest probability for HFpEF in patients with sleep apnea, lung disease, or chronic thromboemboli identifies a progressive gradient for dynamic PCWP abnormalities with worse functional status and quality of life. These subclinical left heart abnormalities are not universally detectable by resting right heart catheterization alone and call for further study of whether strategies to prevent or treat HFpEF might improve functional status in these patients with high risk of occult HFpEF.

Study context

Population
Adjudicated group 3 or 4 patients (lung disease, sleep apnea, chronic thromboemboli) at risk for pulmonary hypertensionpatients with group 3 disease, group 4 disease n=102 · group 3 disease 598 · group 4 disease 102 · heart failure with preserved ejection fraction (HFpEF) without pulmonary vascular disease 61 · combined precapillary and postcapillary pulmonary hypertension HFpEF 31
Participants
598 participants
Comparison
Stratification by current resting right heart catheterization criteria, and separately by HFpEF-ABA probability
  • Intermediate HFpEF probabilityn = 358
  • High (≥75%) HFpEF probabilityn = 197
Outcome
Elevated PCWP with postcapillary pulmonary hypertension at rest (group 3)
Methodological detailsRedefining Pulmonary Hypertension Through Pulmonary Vascular Disease Phenomics
  • Redefining Pulmonary Hypertension Through Pulmonary Vascular Disease Phenomics

Main finding

As reported in the abstract

Elevated pulmonary capillary wedge pressure (PCWP) with postcapillary pulmonary hypertension even at rest

27%

n=161

Further findings

OutcomeIntermediate HFpEF probabilityHigh (≥75%) HFpEF probability
HFpEF-ABA probability distribution (group 3)Regardless of resting PCWP-based classification57%32%

Resting and dynamic PCWP response to NO, fluid, and exercise

High HFpEF probability associated with higher resting and dynamic PCWP
P < 0.0001 for all
Comparable with HFpEF without pulmonary vascular disease (n=61); less severe than combined precapillary and postcapillary pulmonary hypertension HFpEF (n=31)
  • Interaction P =0.006

Left heart remodeling, quality of life, 6-minute walk distance, peak VO 2

Increasing HFpEF probability associated with worse outcomes
P < 0.0001 for all

Replication in group 4 disease

Findings were replicated in group 4 disease (n=102)

Original publication

Left Heart Abnormalities in Patients With Lung Disease, OSA, and Chronic Thromboemboli at Risk for or With Known Pulmonary Hypertension. Circ Heart Fail. Published 29 May 2025. doi:10.1161/circheartfailure.125.012912

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.